Apart from S1P, the S1P receptors, S1P-metabolizing enzymes and sphingosine kinase (SK) have been demonstrated to be aberrantly expressed in various cancers, such as gastric cancer, colon cancer, breast cancer and glioblastoma [4]. This evidence concerns the gene MBTPS1 and breast cancer.